Brief: Hoth Therapeutics Advances Cancer Fighting HT-KIT Program with New Patent Filing and Preclinical Study Initiation
26/03/2025 12:10
March 26 (Reuters) - Hoth Therapeutics Inc HOTH.O: HOTH THERAPEUTICS ADVANCES CANCER FIGHTING HT-KIT PROGRAM WITH NEW PATENT FILING AND PRECLINICAL STUDY INITIATION HOTH THERAPEUTICS INC - FILES AMENDED PATENT CLAIMS FOR HT-KIT TECHNOLOGY HOTH THERAPEUTICS INC - INITIATES 4-WEEK TOXICITY STUDY FOR HT-KIT Source text: ID:nPn77dqR3a Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology